BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29191605)

  • 21. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.
    Shin DH; Choi YJ; Park JW
    Cancer Res; 2014 Jan; 74(1):298-308. PubMed ID: 24240701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
    Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
    J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPK activation by ASP4132 inhibits non-small cell lung cancer cell growth.
    Xia YC; Zha JH; Sang YH; Yin H; Xu GQ; Zhen J; Zhang Y; Yu BT
    Cell Death Dis; 2021 Apr; 12(4):365. PubMed ID: 33824293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner.
    Hsieh FS; Chen YL; Hung MH; Chu PY; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Chang MJ; Chao TI; Shiau CW; Chen KF
    Mol Oncol; 2017 Aug; 11(8):1035-1049. PubMed ID: 28453226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
    PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro.
    Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Yu CS; Wu SH; Lin JG; Chung JG
    Mol Med Rep; 2015 Jul; 12(1):1030-42. PubMed ID: 25815777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner.
    Meng J; Majidi M; Fang B; Ji L; Bekele BN; Minna JD; Roth JA
    PLoS One; 2013; 8(10):e77067. PubMed ID: 24146957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy.
    Wu Y; Si Y; Xiang Y; Zhou T; Liu X; Wu M; Li W; Zhang T; Xiang K; Zhang L; Zhao H; Liu Y
    Arch Biochem Biophys; 2020 Jul; 687():108285. PubMed ID: 32074500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.
    Zuo Z; Urban G; Scammell JG; Dean NM; McLean TK; Aragon I; Honkanen RE
    Biochemistry; 1999 Jul; 38(28):8849-57. PubMed ID: 10413457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
    Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
    Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
    Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
    BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.